• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物递送的仿生脂质聚合物纳米颗粒

Biomimetic Lipid Polymer Nanoparticles for Drug Delivery.

作者信息

Carmona-Ribeiro Ana Maria

机构信息

Biocolloids Laboratory, Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Methods Mol Biol. 2020;2118:45-60. doi: 10.1007/978-1-0716-0319-2_4.

DOI:10.1007/978-1-0716-0319-2_4
PMID:32152970
Abstract

Biomimetic nanoparticles are hybrid nanostructures in which the uppermost layer is similar to a cell membrane. In these nanoparticles, lipids and biopolymers can be organized to improve drug incorporation and delivery. This report provides instructions for the preparation and physical characterization of four different biomimetic nanoparticles: (1) polystyrene sulphate (PSS) nanoparticles covered with one cationic dioctadecyl dimethylammonium bromide bilayer (DODAB), which incorporates dimeric channels of the antimicrobial peptide Gramicidin D; (2) silica nanoparticles covered with one single bilayer of the antimicrobial cationic lipid DODAB; (3) hybrid lipid/polymer indomethacin (IND) nanoparticles from injection of IND/DODAB ethanolic solution in a water solution of carboxymethyl cellulose (CMC); (4) bactericidal and fungicidal nanoparticles from DODAB bilayer fragments (BF) covered consecutively by a CMC and a poly(diallyl dimethyl ammonium chloride) (PDDA) layer. These examples provide the basis for the preparation and characterization of novel biomimetic nanoparticles with lipids and/or biopolymers in their composition. The polymers and lipids in the hybrid nanoparticle composition may impart stability and/or bioactivity and/or provide adequate microenvironments for carrying bioactive drugs and biomolecules.

摘要

仿生纳米颗粒是一种杂化纳米结构,其最外层类似于细胞膜。在这些纳米颗粒中,脂质和生物聚合物可以进行组织排列,以改善药物的掺入和递送。本报告提供了四种不同仿生纳米颗粒的制备方法及物理特性说明:(1)覆盖有一层阳离子二辛基二甲基溴化铵双层(DODAB)的聚苯乙烯硫酸盐(PSS)纳米颗粒,其包含抗菌肽短杆菌肽D的二聚体通道;(2)覆盖有一层抗菌阳离子脂质DODAB单层的二氧化硅纳米颗粒;(3)通过将吲哚美辛(IND)/DODAB乙醇溶液注入羧甲基纤维素(CMC)水溶液中制备的脂质/聚合物杂化吲哚美辛(IND)纳米颗粒;(4)由DODAB双层片段(BF)依次覆盖CMC层和聚二烯丙基二甲基氯化铵(PDDA)层形成的杀菌和杀真菌纳米颗粒。这些实例为制备和表征组成中含有脂质和/或生物聚合物的新型仿生纳米颗粒提供了基础。杂化纳米颗粒组成中的聚合物和脂质可赋予稳定性和/或生物活性,和/或为携带生物活性药物和生物分子提供适宜的微环境。

相似文献

1
Biomimetic Lipid Polymer Nanoparticles for Drug Delivery.用于药物递送的仿生脂质聚合物纳米颗粒
Methods Mol Biol. 2020;2118:45-60. doi: 10.1007/978-1-0716-0319-2_4.
2
Cationic Nanostructures as Adjuvants for Vaccines.阳离子纳米结构作为疫苗佐剂。
Methods Mol Biol. 2022;2412:233-245. doi: 10.1007/978-1-0716-1892-9_10.
3
Antimicrobial particles from cationic lipid and polyelectrolytes.阳离子脂质体和聚电解质的抗菌颗粒。
Langmuir. 2010 Jul 20;26(14):12300-6. doi: 10.1021/la101500s.
4
Preparation and characterization of biomimetic nanoparticles for drug delivery.用于药物递送的仿生纳米颗粒的制备与表征
Methods Mol Biol. 2012;906:283-94. doi: 10.1007/978-1-61779-953-2_22.
5
Microbicidal Dispersions and Coatings from Hybrid Nanoparticles of Poly (Methyl Methacrylate), Poly (Diallyl Dimethyl Ammonium) Chloride, Lipids, and Surfactants.聚甲基丙烯酸甲酯、聚二烯丙基二甲基氯化铵、脂质和表面活性剂的混合纳米粒子的杀菌分散体和涂层。
Int J Mol Sci. 2019 Dec 6;20(24):6150. doi: 10.3390/ijms20246150.
6
Cationic Biomimetic Particles of Polystyrene/Cationic Bilayer/Gramicidin for Optimal Bactericidal Activity.用于实现最佳杀菌活性的聚苯乙烯/阳离子双层/短杆菌肽阳离子仿生颗粒
Nanomaterials (Basel). 2017 Dec 2;7(12):422. doi: 10.3390/nano7120422.
7
Colloid stability of lipid/polyelectrolyte decorated latex.脂质/聚电解质修饰乳胶的胶体稳定性
Langmuir. 2004 Oct 26;20(22):9535-40. doi: 10.1021/la048938j.
8
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.脂质-聚合物杂化纳米颗粒作为新一代治疗性递送平台:综述
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17.
9
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.影响载药脂质-聚合物杂化纳米粒包封率和稳定性的因素。
Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):214-20. doi: 10.1016/j.colsurfb.2011.02.033. Epub 2011 Mar 2.
10
Supramolecular assemblies of rifampicin and cationic bilayers: preparation, characterization and micobactericidal activity.利福平与阳离子双层的超分子组装体:制备、表征和分枝杆菌杀菌活性。
BMC Biotechnol. 2011 Apr 15;11:40. doi: 10.1186/1472-6750-11-40.

引用本文的文献

1
Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation.脂质聚合物杂化纳米粒子对抗肺癌及其作为吸入制剂的应用。
Nanomedicine (Lond). 2024;19(25):2113-2133. doi: 10.1080/17435889.2024.2387530. Epub 2024 Aug 15.
2
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.脂质聚合物杂化纳米粒:一种为癌症治疗定制的新一代方法。
Mol Cancer. 2023 Oct 3;22(1):160. doi: 10.1186/s12943-023-01849-0.
3
Recent Advances in the Development of Lipid-, Metal-, Carbon-, and Polymer-Based Nanomaterials for Antibacterial Applications.
用于抗菌应用的脂质基、金属基、碳基和聚合物基纳米材料开发的最新进展
Nanomaterials (Basel). 2022 Nov 1;12(21):3855. doi: 10.3390/nano12213855.
4
Supramolecular Nanostructures for Vaccines.用于疫苗的超分子纳米结构
Biomimetics (Basel). 2021 Dec 29;7(1):6. doi: 10.3390/biomimetics7010006.
5
Cationic Nanostructures as Adjuvants for Vaccines.阳离子纳米结构作为疫苗佐剂。
Methods Mol Biol. 2022;2412:233-245. doi: 10.1007/978-1-0716-1892-9_10.
6
Antimicrobial Polymer-Based Assemblies: A Review.基于抗菌聚合物的组装体:综述。
Int J Mol Sci. 2021 May 21;22(11):5424. doi: 10.3390/ijms22115424.
7
Effect of DODAB Nano-Sized Cationic Bilayer Fragments against .DODAB 纳米尺寸阳离子双层片段对 的影响。
Molecules. 2020 Dec 5;25(23):5741. doi: 10.3390/molecules25235741.
8
Cationic Nanostructures for Vaccines Design.用于疫苗设计的阳离子纳米结构
Biomimetics (Basel). 2020 Jul 7;5(3):32. doi: 10.3390/biomimetics5030032.